In a 4-arm, randomized controlled trial, we will evaluate the relative effectiveness and cost-effectiveness of improving cholesterol levels among participants who are at high risk of CVD and who have elevated LDL cholesterol levels by testing process versus outcomes financial incentives. Participants will use electronic pill bottles that continuously monitor statin adherence. The primary outcome will be change in LDL cholesterol over 12 months.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
764
Daily sweepstake conditional on daily medication adherence
Incentives conditional on LDL cholesterol reduction
University of Pennsylvania
Philadelphia, Pennsylvania, United States
Change in LDL cholesterol from baseline to 12 months
Time frame: 12 months
Statin Adherence
Time frame: 18 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.